 |
|
Diabetes and Mortality Following Acute Coronary Syndromes
Sean M. Donahoe, MD;
Garrick C. Stewart, MD;
Carolyn H. McCabe, BS;
Satishkumar Mohanavelu, MS;
Sabina A. Murphy, MPH;
Christopher P. Cannon, MD;
Elliott M. Antman, MD
JAMA. 2007;298:765-775.
Context The worldwide epidemic of diabetes mellitus is increasing the burden of cardiovascular disease, the leading cause of death among persons with diabetes. The independent effect of diabetes on mortality following acute coronary syndromes (ACS) is uncertain.
Objective To evaluate the influence of diabetes on mortality following ACS using a large database spanning the full spectrum of ACS.
Design, Setting, and Patients A subgroup analysis of patients with diabetes enrolled in randomized clinical trials that evaluated ACS therapies. Patients with ACS in 11 independent Thrombolysis in Myocardial Infarction (TIMI) Study Group clinical trials from 1997 to 2006 were pooled, including 62 036 patients (46 577 with ST-segment elevation myocardial infarction [STEMI] and 15 459 with unstable angina/non-STEMI [UA/NSTEMI]), of whom 10 613 (17.1%) had diabetes. A multivariable model was constructed to adjust for baseline characteristics, aspects of ACS presentation, and treatments for the ACS event.
Main Outcome Measures Mortality at 30 days and 1 year following ACS among patients with diabetes vs patients without diabetes.
Results Mortality at 30 days was significantly higher among patients with diabetes than without diabetes presenting with UA/NSTEMI (2.1% vs 1.1%, P < .001) and STEMI (8.5% vs 5.4%, P < .001). After adjusting for baseline characteristics and features and management of the ACS event, diabetes was independently associated with higher 30-day mortality after UA/NSTEMI (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.24-2.56) or STEMI (OR, 1.40; 95% CI, 1.24-1.57). Diabetes at presentation with ACS was associated with significantly higher mortality 1 year after UA/NSTEMI (hazard ratio [HR], 1.65; 95% CI, 1.30-2.10) or STEMI (HR, 1.22; 95% CI, 1.08-1.38). By 1 year following ACS, patients with diabetes presenting with UA/NSTEMI had a risk of death that approached patients without diabetes presenting with STEMI (7.2% vs 8.1%).
Conclusion Despite modern therapies for ACS, diabetes confers a significant adverse prognosis, which highlights the importance of aggressive strategies to manage this high-risk population with unstable ischemic heart disease.
Author Affiliations: The TIMI Study Group; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Drs Stewart, Cannon, and Antman, and Mr Mohanavelu and Mss McCabe and Murphy); and Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York, New York (Dr Donahoe).
RELATED LETTERS
Diabetes and Mortality Risk After Acute Coronary Syndromes
Manivannan Srinivasan and Sumit Bhagra
JAMA. 2007;298(20):2367.
EXTRACT
| FULL TEXT
Diabetes and Mortality Risk After Acute Coronary Syndromes
Kapil Parakh
JAMA. 2007;298(20):2367-2368.
EXTRACT
| FULL TEXT
Glucose-Insulin-Potassium Therapy in Patients With STEMI
Harry P. Selker, Joanne Ingwall, and Charles E. Rackley
JAMA. 2008;299(20):2385.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Acute Coronary Syndromes
John L. Zeller, Alison E. Burke, and Richard M. Glass
JAMA. 2007;298(7):828.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Glucose-Insulin-Potassium Therapy in Patients With STEMI
Selker et al.
JAMA 2008;299:2385-2385.
FULL TEXT
Impact of Drug-Eluting Stents Among Insulin-Treated Diabetic Patients: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry
Mulukutla et al.
J Am Coll Cardiol Intv 2008;1:139-147.
ABSTRACT
| FULL TEXT
LDL Cholesterol Lowering in Type 2 Diabetes: What Is the Optimum Approach?
Nesto
Clin. Diabetes 2008;26:8-13.
ABSTRACT
| FULL TEXT
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Ferdinandy et al.
Pharmacol. Rev. 2007;59:418-458.
ABSTRACT
| FULL TEXT
Diabetes and Mortality Risk After Acute Coronary Syndromes
Srinivasan and Bhagra
JAMA 2007;298:2367-2367.
FULL TEXT
Diabetes and Mortality Risk After Acute Coronary Syndromes
Parakh
JAMA 2007;298:2367-2368.
FULL TEXT
Diabetes Contributes to Acute Coronary Syndromes Death
DOC News 2007;4:15-15.
FULL TEXT
Diabetes Increases Short-Term Mortality Risk in Patients with Acute Coronary Syndromes
JWatch Emergency Med. 2007;2007:2-2.
FULL TEXT
Patients with Diabetes Fare Worse After MI Than Those Without Diabetes
Journal Watch Cardiology 2007;2007:4-4.
FULL TEXT
|
